Latest updates for Biotech Food Drug
Fresh curated links around Biotech Food Drug are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe
- <![CDATA[Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program]]>
- Nu-Tek Brings Topic of Raw-Material Risk to BPI
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
<![CDATA[Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program]]>
Nu-Tek Brings Topic of Raw-Material Risk to BPI
Nu-Tek BioSciences will use BPI East to highlight animal-origin-free peptones and hydrolysates designed to strengthen media consistency, reduce raw-material risk, and support more...
APEC Holds High-Level Policy Dialogue on Agricultural Biotechnology
U.S Biotech Day 2026
U.S. Biotech Day is a premier gathering of biotechnology and life sciences leaders, bringing together biotech companies, pharmaceutical organizations, investors, researchers, and s...
<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...
<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...
Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute
Teva believes the therapy has “pipeline-in-a-product” potential. Elsewhere, a high-stakes trial was paused and GSK advanced a competitor to Moderna’s flu shot.
<![CDATA[Roundup: AbbVie & Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]>
APHIS Begins Comment Period on Petitions to Deregulate Herbicide-Resistant Cottons Developed Using Genetic Engineering
The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced on September 21, 2026, that it has received two petitions from Bayer U.S.-C...
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand...
Biologics Standards for Innovation, Quality and Access
This GEN Spotlight on Biologics Standards for Innovation, Quality and Access brings together experts from across biopharma, standards development, and analytical science to examine...
BioXcel
BioXcel Anonymous (not verified) Sun, 08/30/2026 - 09:43 field_thread_url https://cafepharma.com/boards/threads/bioxcel.674502/ board na...
Health Ministry approves biovigilance programme to monitor adverse drug reactions
The programme will focus on reporting, assessment, monitoring and prevention of adverse events associated with medicines and biological products used in organ and tissue transplant
Bipartisan, Bicameral Bills Would Designate Biotechnology and Biomanufacturing as Critical Infrastructure
Bayer to bring 10 products to world market in 10 years
In soy, ‘Vyconic 1’ is expected to be introduced next year in the US and Canada, and ‘Intacta 5+’ is expected to be introduced in the 2027-28 growing season in Brazil
<![CDATA[Cellectis Transforming Into In Vivo Gene Editing Company]]>
Samsung Biologics highlights faster drug manufacturing timelines at BPI Boston
Samsung Biologics showcased manufacturing technologies designed to accelerate biopharmaceutical development and improve product quality at BioProcess International (BPI) 2026 in Bo...
Biotech industry calls for €450m investment in food innovation
The agriculture sector has called on the government to invest €450 million in food technology to maintain the Netherlands’ status...
<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>
India’s biotech start-ups need patient capital to drive novel drug innovation, industry leaders say
Industry leaders call for bigger investments, policy predictability, risk capital pool, and more, at CII Pharma and Life Sciences Summit
Startup Arboretum Sprouts, Bringing a Precision Medicine Approach to Common Diseases
Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say analyses of data from its genetic tests both form the bas...
eGreen Biotek Expands Its Global Medicinal Mushroom Supply Strategy Through U.S. Collaboration
Taiwan mushroom biotechnology company eGreen Biotek is advancing a U.S. collaboration with AMP Laboratory to connect ingredient development, cultivation and manufacturing capabilit...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.